Format

Send to

Choose Destination
Pituitary. 2017 Oct;20(5):489-498. doi: 10.1007/s11102-017-0838-2.

Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement.

Author information

1
Division of Endocrinology, Santiago de Compostela University, Santiago de Compostela, Spain. endocrine@usc.es.
2
Division of Endocrinology, University of Michigan Health System, Ann Arbor, MI, USA.
3
Department of Neurosurgery, University Hospital Erlangen, Erlangen, Germany.
4
Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA, USA.
5
Department of Neurosurgery, Brigham & Women's Hospital, Boston, MA, USA.
6
Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
7
Cedars-Sinai Medical Center, Los Angeles, CA, USA.
8
Department of Neurosurgery, San Raffaele University Health Institute Milan, Milan, Italy.
9
Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, UK.
10
Division of Endocrinology, San Raffaele University Hospital, Milan, Italy.

Abstract

INTRODUCTION:

With the goal of generate uniform criteria among centers dealing with pituitary tumors and to enhance patient care, the Pituitary Society decided to generate criteria for developing Pituitary Tumors Centers of Excellence (PTCOE).

METHODS:

To develop that task, a group of ten experts served as a Task Force and through two years of iterative work an initial draft was elaborated. This draft was discussed, modified and finally approved by the Board of Directors of the Pituitary Society. Such document was presented and debated at a specific session of the Congress of the Pituitary Society, Orlando 2017, and suggestions were incorporated. Finally the document was distributed to a large group of global experts that introduced further modifications with final endorsement.

RESULTS:

After five years of iterative work a document with the ideal criteria for a PTCOE is presented.

CONCLUSIONS:

Acknowledging that very few centers in the world, if any, likely fulfill the requirements here presented, the document may be a tool to guide improvements of care delivery to patients with pituitary disorders. All these criteria must be accommodated to the regulations and organization of Health of a given country.

KEYWORDS:

Acromegaly; Cushing’s disease; Gonadotropins; Pituitary radiotherapy; Thyrotropinomas; Transsphenoidal surgery

PMID:
28884415
PMCID:
PMC5606938
DOI:
10.1007/s11102-017-0838-2
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center